ARTICLE | Company News
Clayton Foundation for Research, Renova Therapeutics deal
October 17, 2016 7:00 AM UTC
Research Development Foundation, the nonprofit supporting organization of The Clayton Foundation, granted Renova an exclusive, worldwide license to the patent for the urocortin 3 (Ucn3) gene. Renova...